1 completed, 1 terminated. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Terminated 1 |
| Phase 3 | 1 | Terminated 1 |
Follow Receptor, EphB4: new trials by email Literature Review of Receptor, EphB4 trials Research Report on Receptor, EphB4
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Custodiol Versus Blood Cardioplegaia in Paediatric Cardiac Surgery Custodiol Solution, Blood cardioplegia - Congenital Heart Disease | Phase 2 | Completed | King Faisal Specialist Hospital & Research Center | 49 | 2016-03-16 | 2023-04-13 |
| TOP-Study (Tacrolimus Organ Perfusion): Treatment of Ischemia Reperfusion Injury in Marginal Organs With an ex Vivo Tacrolimus Perfusion Tacrolimus, HTK/Placebo - Terminal Liver Disease, Ischemia Reperfusion Injury | Phase 2 / Phase 3 | Terminated | Ludwig-Maximilians - University of Munich | 25 | 2011-10-01 | 2017-03-23 |
Heart Defects, Congenital (1) · Reperfusion Injury (1)
King Faisal Specialist Hospital & Research Center (1) · Ludwig-Maximilians - University of Munich (1)
Germany (1) · Saudi Arabia (1)
Karl-Walter Jauch, M.D. (1) · Martin Angele, M.D. (1) · Sebastian Pratschke, M.D. (1)
PMID 18812735, PMID 23263337, PMID 23462260, PMID 23497558, PMID 27500266, PMID 37798628